Inventor · disambiguated record
Hyea Kyung Ahn
Also filed as: AHN HYEA-KYUNG
5 granted patents·9 pending applications·6 citations·filing 2003–2024
70Inventor score
Top patents by PatentIndex Score
14 records- 0187US2025026835A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0284US10544226B2Antibody binding to FcRn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2015·Granted Jan 28, 2020·4 cites·21 claims
- 0384US2024092913A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0483US11613578B2Antibody binding to FCRN for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·23 claims
- 0581US2023235063A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0675US10336825B2Antibody binding to FcRn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2017·Granted Jul 2, 2019·1 cites·4 claims
- 0763US2019135917A1Antibody binding to fcrn for treating autoimmune diseasesHANALL BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0852US2024287191A1Formulation for anti-fcrn antibodyHANALL BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0951US2003228666A1Novel human thrombopoietin muteinDAE WOONG PHARMA·Filed 2003·Application pending·0 cites
- 1050US2024059768A1A stable ophthalmic composition comprising tanfanercept, which is free of stabilizer or substantially free of stabilizerHANALL BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1150US2024059767A1Treatment of dry eye syndrome using an ophthalmic composition comprising tanfanerceptHANALL BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1248US7037491B2Human thrombopoietin comprising glycosylation sited at residues 157 and 164DAE WOONG PHARMA·Filed 2005·Granted May 2, 2006·0 cites·7 claims
- 1345US2007264710A1Process for Purifying Human Thrombopoietin with High Content of Sialic AcidAHN HYEA-KYUNG·Filed 2003·Application pending·0 cites
- 1442US9580490B2Uses of modified human tumor necrosis factor receptor-1 polypeptideHANALL BIOPHARMA CO LTD·Filed 2013·Granted Feb 28, 2017·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Hyea Kyung Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →